DICE Therapeutics (DICE) Income Statement (2021 - 2023)
Income Statement report data from Sep 30, 2021 to Jun 30, 2023 for DICE Therapeutics (DICE).
Reported currency: USD
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|
Operating Expenses | ||||||||
Research And Development | 28M (+19.19%) | 24M (+17.77%) | 20M (+36.39%) | 15M (+2.79%) | 14M (+6.86%) | 13M (+9.83%) | 12M (+4.45%) | 12M |
Selling General And Administrative | 11M (+42.86%) | 7.91M (+24.37%) | 6.36M (-1.24%) | 6.44M (-13.09%) | 7.41M (+35.96%) | 5.45M (+36.25%) | 4.00M (-9.91%) | 4.44M |
Operating Expenses | 40M (+25.08%) | 32M (+19.40%) | 26M (+24.94%) | 21M (-2.62%) | 22M (+15.27%) | 19M (+16.35%) | 16M (+0.50%) | 16M |
Operating Income | ||||||||
Operating Income | -39.50M (+25.12%) | -31.57M (+19.36%) | -26.45M (+24.94%) | -21.17M (-2.62%) | -21.74M (+15.27%) | -18.86M (+16.35%) | -16.21M (+0.50%) | -16.13M |
EBITDA | -38.81M (+25.44%) | -30.94M (+12.76%) | -27.44M (+29.62%) | -21.17M (+0.62%) | -21.04M (+14.72%) | -18.34M (+14.27%) | -16.05M (+0.38%) | -15.99M |
Other Income / Expenses | ||||||||
Interest Income | 4.68M (-21.08%) | 5.93M (+60.27%) | 3.70M (+428.57%) | 700K (+42.86%) | 490K (+48.48%) | 330K (+312.50%) | 80K (+300.00%) | 20K |
Interest Expense | - | - | -470.00K (+487.50%) | -80.00K (+33.33%) | -60.00K (0.00%) | -60.00K (0.00%) | -60.00K (0.00%) | -60.00K |
Net Interest Income | 4.68M (-21.08%) | 5.93M (+42.21%) | 4.17M (+427.85%) | 790K (+43.64%) | 550K (+41.03%) | 390K (+178.57%) | 140K (+75.00%) | 80K |
Other Non Operating Income | - | - | - | - | -200.00K | - | - | -1.16M |
Net Income | ||||||||
Income Before Tax | -34.82M (+35.75%) | -25.65M (+10.47%) | -23.22M (+12.99%) | -20.55M (-4.51%) | -21.52M (+15.76%) | -18.59M (+14.82%) | -16.19M (-6.58%) | -17.33M |
Net Income From Continuing Operations | -34.82M (+35.75%) | -25.65M (+10.47%) | -23.22M (+12.99%) | -20.55M (-4.51%) | -21.52M (+15.76%) | -18.59M (+14.82%) | -16.19M (-6.58%) | -17.33M |
Net Income | -34.82M (+35.75%) | -25.65M (+10.47%) | -23.22M (+12.99%) | -20.55M (-4.51%) | -21.52M (+15.76%) | -18.59M (+14.82%) | -16.19M (-6.58%) | -17.33M |